NGM Biopharmaceuticals Aktie

Watchlist NGM WKN A2N7B5 ISIN US62921N1054
- -
-

Was macht NGM Biopharmaceuticals?

Unternehmensprofil
Unternehmensprofil

NGM Biopharmaceuticals is a privately-held drug discovery company committed to identifying transformational medicines that dramatically improve human health. Based on emerging human clinical and genetic observations, the company has devised several innovative experimental approaches to discover new therapies for the treatment of metabolic and cardiovascular diseases. The company's current focus is on the gastrointestinal endocrine system, with an aim to identify novel factors implicated in the pathogenesis of type 2 diabetes and the apparent resolution of this grievous disease in patients who have undergone gastric bypass surgery.

Chart der NGM Biopharmaceuticals Aktie

Charttool öffnen

Aktuelle Nachrichten zu NGM Biopharmaceuticals

Weitere Nachrichten

Das berichten andere über NGM Biopharmaceuticals

NGM Bio Announces Closing of Tender Offer

SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (“NGM Bio”) (Nasdaq: NGM), a biotechnology company focused on discovering and developing...

www.globenewswire.com